Prescription Drug Marketing Act

You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.

This article refers to a federal law. For other meanings, see PDMA.

The Prescription Drug Marketing Act (PDMA) of 1987 (P.L. 100-293, 102 Stat. 95) is a law of the United States federal government. It establishes legal safeguards for prescription drug distribution to ensure safe and effective pharmaceuticals. It's designed to discourage the sale of counterfeit, adulterated, misbranded, subpotent, and expired prescription drugs. It was passed in response to the development of a wholesale sub-market (known as the "diversion market") for prescription drugs.

The PDMA was modified by the Prescription Drug Amendments of 1992 (P.L. 102-353, 106 Stat. 941) on August 26 1992.

See also

• Regulation of therapeutic goods
• Good Distribution Practice
• Food and Drug Administration (FDA, USA)
• Pharmaceutical marketing
• Disease mongering

External links

• U.S. Food and Drug Administration's Report to Congress, June 2001
• U.S. Food and Drug Administration's Report to Congress, June 2001 (PDF)
• California Department of Health Services Website, Food and Drug Branch page (State agency provides background on federal PDMA)Template:US-law-stub